| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC60611 | Compound 32 (HER2) Featured | Compound 32 (HER2) is a potent and selective covalent inhibitor of HER2/WT and HER2/YVMA with IC50 of 49 nM and 42 nM, respectively. |
.jpg)
|
| DC60612 | IDOR-1117-2520 Featured | IDOR-1117-2520 is a selective and insurmountable antagonist of CCR6 with IC50 of 20 nM. |
|
| DC66543 | Pidobenzone Featured | Pidobenzone is a dermatologic agent. |
|
| DC66544 | Pseudouridine 5'-triphosphate trisodium Featured | Pseudouridine-5’-triphosphate (Pseudo-UTP) is one of the most commonly used modified nucleoside for the polymerase-mediated synthesis of RNA molecules. Compared with uridine-containing unmodified mRNAs, the application of pseudouridine-containing modified mRNAs exhibits better nuclease stability, immunogenicity, and translational properties. |
|
| DC66545 | 5-Bromo Brassinin Featured |
.png)
|
|
| DC60613 | LSN3441732 Featured | LSN3441732 is a dimeric compound and inhibits the formation of Lipoprotein(a) (Lp(a)) particles in vitro with IC50 of 0.18 nM. |
|
| DC66546 | R-Sirpiglenastat Featured | R-Sirpiglenastat is the R- isomer of Sirpiglenastat(DRP-104).Sirpiglenastat (DRP104) is a broad acting glutamine antagonist. Sirpiglenastat has anticancer effects by directly targeting tumor metabolism and simultaneously inducing a potent antitumor immune response. |
|
| DC66547 | SL25 intermediate 16 Featured |
|
|
| DC60614 | BIO-8169 Featured | BIO-8169 is a highly potent, selective, and brain-penetrant IRAK4 inhibitor with IC50 of 0.2 nM. BIO-8169 has an excellent PK profile, reduces the in vivo production of pro-inflammatory cytokines, and is tolerated in toxicity studies in rodents and dogs. |
|
| DC60615 | Nelutroctiv (CK-136) Featured | Nelutroctiv (CK-136) is a novel cardiac troponin activator devoid of PDE-3 activity that demonstrates a wider pharmacodynamic window in vivo relative to a representative myosin activator, CK-138. |
_1.jpg)
|
| DC60616 | TERT activator compound tac Featured | TAC is a TERT activator compound that upregulates TERT transcription via the MEK/ERK/AP-1 cascade. TAC alleviates neuroinflammation, increases neurotrophic factors, stimulates adult neurogenesis, and preserves cognitive function without evident toxicity, including cancer risk. |
|
| DC66548 | GalNAc-Lipid GL3 Featured |
|
|
| DC66549 | GalNAc-NAG-37 Phosphoramidite Featured |
|
|
| DC66550 | GalNAc-Cluster-COOH Featured |
|
|
| DC66551 | GalNAc-Cluster-HHA-CE Phosphoramidite Featured |
|
|
| DC66552 | PAM-Acid derivatives Featured |
|
|
| DC66553 | PAM-Acid Featured |
.png)
|
|
| DC66554 | AdemC-GalNAc Phosphoramidite Featured |
|
|
| DC66555 | GalNAc-L96 Linker-Acid Featured |
|
|
| DC66556 | GalNAc PEG Cluster Phosphoramidite Featured |
|
|
| DC66557 | GalNAc-L96 Linker-Azide Featured |
|
|
| DC66558 | Propargyl PEG Linker Phosphoramidi Featured |
|
|
| DC66559 | Peracetylated GalNAc PEG linker-Azide Featured |
|
|
| DC66560 | GalNAc-L96-tert-butyl ester Featured | GalNAc-L96-tert-butyl ester is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-Tri-(t-butoxycarbonylethoxymethyl)-methane is also a PEG/Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs. |
|
| DC66561 | Peracetylated GalNAc succinimidyl pentanoate Featured |
|
|
| DC66562 | Peracetylated GalNAc-C3-Amine-1 Featured |
|
|
| DC66563 | Peracetylated GalNAc-L96-Acid-2 Featured |
|
|
| DC66564 | Peracetylated GalNAc PEG linker-Acid-1 Featured |
|
|
| DC66565 | Peracetylated GalNAc-L96-Acid-1 Featured |
|
|
| DC66566 | Peracetylated GalNAc-L96-Amide-1 Featured |
|
